X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (9) 9
article (7) 7
adenocarcinoma (5) 5
cancer (5) 5
dna methylation (5) 5
female (5) 5
genomics (5) 5
mutation (5) 5
dna (4) 4
genetic aspects (4) 4
multidisciplinary sciences (4) 4
pathology (4) 4
analysis (3) 3
animals (3) 3
breast (3) 3
deoxyribonucleic acid--dna (3) 3
diagnosis (3) 3
evolution (3) 3
genes (3) 3
genome-wide analyses (3) 3
glioblastoma (3) 3
long-term survivor (3) 3
mutation - genetics (3) 3
oncology (3) 3
pancreas (3) 3
pancreatic cancer (3) 3
pancreatic neoplasms - pathology (3) 3
therapy (3) 3
antibodies, monoclonal - pharmacology (2) 2
antibodies, monoclonal - therapeutic use (2) 2
brain (2) 2
carcinoma in situ - classification (2) 2
carcinoma in situ - pathology (2) 2
carcinoma, pancreatic ductal - pathology (2) 2
care and treatment (2) 2
cell biology (2) 2
clonal hematopoiesis (2) 2
colorectal-cancer (2) 2
copy number (2) 2
dna copy number variations - genetics (2) 2
drug resistance, neoplasm - genetics (2) 2
endocrine system diseases (2) 2
epigenetics (2) 2
genomes (2) 2
invasiveness (2) 2
k-ras mutations (2) 2
lung cancer (2) 2
male (2) 2
medical colleges (2) 2
neurosciences (2) 2
p53 protein (2) 2
pancreatic neoplasms - classification (2) 2
pancreatic neoplasms - genetics (2) 2
patients (2) 2
plasma (2) 2
proto-oncogene proteins p21 - genetics (2) 2
research (2) 2
resistance (2) 2
sequence (2) 2
somatic mutations (2) 2
surgery (2) 2
treatment outcome (2) 2
tumors (2) 2
aberrant methylation (1) 1
aberration (1) 1
aberrations (1) 1
acquired-resistance (1) 1
activating mutations (1) 1
adult (1) 1
aging (1) 1
alleles (1) 1
alterations (1) 1
animals, wild (1) 1
animals; antibodies, monoclonal; antineoplastic agents; cetuximab; colorectal neoplasms; dna copy number variations; drug resistance, neoplasm; exome; female; genome, human; humans; insulin receptor substrate proteins; map kinase kinase 1; mice; molecular targeted therapy; mutation; proto-oncogene proteins p21; receptor, epidermal growth factor; receptor, erbb-2; receptor, fibroblast growth factor, type 1; receptor, platelet-derived growth factor alpha; xenograft model antitumor assays; genomics; multidisciplinary (1) 1
antibodies (1) 1
antigens, neoplasm - immunology (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, immunological - pharmacology (1) 1
antineoplastic agents, immunological - therapeutic use (1) 1
bile duct (1) 1
bioinformatics (1) 1
biomarkers (1) 1
biomarkers, tumor (1) 1
biopsy (1) 1
blood (1) 1
blood cells (1) 1
blood cells - metabolism (1) 1
blutzelle (1) 1
brain cancer (1) 1
brca1 protein (1) 1
brca2 mutations (1) 1
brca2 protein (1) 1
breast cancer (1) 1
cancer genes (1) 1
cancer metastasis (1) 1
cancer patients (1) 1
cancer therapies (1) 1
carcinoma (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7572, pp. 263 - 267
Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly... 
PANITUMUMAB | THERAPY | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ACQUIRED-RESISTANCE | SOMATIC MUTATION | IDENTIFICATION | GENE COPY NUMBER | ACTIVATING MUTATIONS | BREAST | INSIGHTS | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Genomics | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | MAP Kinase Kinase 1 - genetics | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Insulin Receptor Substrate Proteins - genetics | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Cetuximab - pharmacology | DNA Copy Number Variations - genetics | Mutation - genetics | Genome, Human - genetics | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Exome - genetics | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Gene mutations | Colorectal cancer | Drug metabolism | Genetic aspects | Identification and classification | Health aspects | Proteins | Epidermal growth factor | Genes | Clinical trials | Mutation | Kinases | Cancer therapies | Tumors
Journal Article
Cancer Discovery, ISSN 2159-8274, 03/2017, Volume 7, Issue 3, pp. 264 - 276
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors containing increased mutation-associated neoantigen load. We have... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | ONCOLOGY | PD-1 BLOCKADE | COLORECTAL-CANCER | PANCREATIC-CANCER | COPY NUMBER | RESISTANCE | MUTATIONS | SEQUENCING DATA | TUMOR PURITY | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Ipilimumab - pharmacology | Immunotherapy | Ipilimumab - therapeutic use | Janus Kinase 1 - genetics | Adult | Female | Receptors, Antigen, T-Cell - immunology | Cell Cycle Checkpoints - immunology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Receptors, Antigen, T-Cell - metabolism | Antigens, Neoplasm - immunology | Carcinoma, Non-Small-Cell Lung - genetics | Antibodies, Monoclonal - pharmacology | Janus Kinase 2 - genetics | CTLA-4 Antigen - genetics | Drug Resistance, Neoplasm - immunology | Lung Neoplasms - therapy | CTLA-4 Antigen - immunology | Antineoplastic Agents, Immunological - pharmacology | Carcinoma, Non-Small-Cell Lung - immunology | Carcinoma, Non-Small-Cell Lung - therapy | Drug Resistance, Neoplasm - genetics | Lung Neoplasms - immunology | Antineoplastic Agents, Immunological - therapeutic use | Cell Cycle Checkpoints - drug effects | Receptors, Antigen, T-Cell - genetics | Mutation | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | Cohort Studies
Journal Article
Nature, ISSN 0028-0836, 2019, Volume 570, Issue 7761, pp. 385 - 389
Journal Article
Science translational medicine, ISSN 1946-6242, 2017, Volume 9, Issue 403, p. eaan2415
Journal Article
by Raphael, Benjamin J and Hruban, Ralph H and Aguirre, Andrew J and Moffitt, Richard A and Yeh, Jen Jen and Stewart, Chip and Robertson, A. Gordon and Cherniack, Andrew D and Gupta, Manaswi and Getz, Gad and Gabriel, Stacey B and Meyerson, Matthew and Cibulskis, Carrie and Fei, Suzanne S and Hinoue, Toshinori and Shen, Hui and Laird, Peter W and Ling, Shiyun and Lu, Yiling and Mills, Gordon B and Akbani, Rehan and Loher, Phillipe and Londin, Eric R and Rigoutsos, Isidore and Telonis, Aristeidis G and Gibb, Ewan A and Goldenberg, Anna and Mezlini, Aziz M and Hoadley, Katherine A and Collisson, Eric and Lander, Eric and Murray, Bradley A and Hess, Julian and Rosenberg, Mara and Bergelson, Louis and Zhang, Wei and Zhang, Hailei and Zhang, Jiashan (Julia) and Zhang, Lizhi and Cho, Juok and Tiao, Grace and Kim, Seong Hoon and Kim, Hark and Kim, Jaegil and Kim, Paula and Kim, Yong Hoon and Livitz, Dimitri and Leshchiner, Ignaty and Reardon, Brendan and Van Allen, Eliezer and Kamburov, Atanas and Beroukhim, Rameen and Saksena, Gordon and Schumacher, Steven E and Noble, Michael S and Heiman, David I and Gehlenborg, Nils and Lawrence, Michael S and Adsay, Volkan and Petersen, Gloria and Klimstra, David and Bardeesy, Nabeel and Leiserson, Mark D.M and Bowlby, Reanne and Kasaian, Katayoon and Birol, Inanc and Mungall, Andrew J and Mungall, Karen L and Sadeghi, Sara and Weinstein, John N and Spellman, Paul T and Liu, Yuexin and Liu, Jia and Amundadottir, Laufey T and Tepper, Joel and Singhi, Aatur D and Dhir, Rajiv and Paul, Drwiega and Smyrk, Thomas and Bowen, Jay and Frick, Jessica and Gastier-Foster, Julie M and Gerken, Mark and Lau, Kevin and Leraas, Kristen M and Lichtenberg, Tara M and Ramirez, Nilsa C and Renkel, Jeremy and Sherman, Mark and Wise, Lisa and Yena, Peggy and Zmuda, Erik and Shih, Juliann and Ally, Adrian and Balasundaram, Miruna and Carlsen, Rebecca and Chu, Andy and Chuah, Eric and Clarke, Amanda and Dhalla, Noreen and ... and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu and Cancer Genome Atlas Research Network
Cancer Cell, ISSN 1535-6108, 08/2017, Volume 32, Issue 2, pp. 185 - 203.e13
Journal Article
Advances In Anatomic Pathology, ISSN 1072-4109, 01/2019, Volume 26, Issue 1, pp. 31 - 39
Although pathologic lesions in the pancreas are 3-dimensional (3D) complex structures, we currently use thin 2D hematoxylin and eosin stained slides to study... 
Journal Article
American journal of surgical pathology, ISSN 0147-5185, 2004, Volume 28, Issue 8, pp. 977 - 987
Journal Article